Dilated cardiomyopathy

Board exam relevance: in 7 of more than 100 exam reports · rank 53
Synonyms
DCM, enlarged heart, congestive cardiomyopathy
Specialty
Internal medicine · Cardiology
Images
X-ray 1 · Gross specimen 1 · Echocardiography 1
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (3)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Diagnosis
  8. Treatment principles
  9. Keep learning in the app
  10. Further reading (open access)
  11. Cross-references

Images (3)

Dilated cardiomyopathy – Chest X-ray PA: marked global cardiomegaly with the cardiac silhouette extending to the left, cardiothoracic ratio well above 0.5X-ray
Chest X-ray PA: marked global cardiomegaly with the cardiac silhouette extending to the left, cardiothoracic ratio well above 0.5Image: James Heilman, MD (Wikimedia Commons) · CC BY-SA 4.0 · Source
Dilated cardiomyopathy – gross specimen: Autopsy: opened, dilated left ventricle with whitish subendocardial fibrosis in idiopathic cardiomyopathyGross specimen
Autopsy: opened, dilated left ventricle with whitish subendocardial fibrosis in idiopathic cardiomyopathyImage: CDC/Dr. Edwin P. Ewing, Jr. (Wikimedia Commons) · Public Domain · Source · CDC PHIL #852 · cropped
Dilated cardiomyopathy – echocardiography: M-mode of the left ventricle: markedly dilated ventricle (about 7 cm end-diastolic) with reduced wall motionEchocardiography
M-mode of the left ventricle: markedly dilated ventricle (about 7 cm end-diastolic) with reduced wall motionImage: CardioNetworks: Secretariat, “Dilated cardiomyopathy with severe mitral valve regurgitation E00139 (CardioNetworks ECHOpedia)” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
1 / 3

Definition

Dilated cardiomyopathy (DCM) is a primary myocardial disorder with dilatation and systolic dysfunction of the left or both ventricles that is not sufficiently explained by congenital heart disease, abnormal loading conditions (e.g. primary valve disease) or coronary artery disease. It is regarded as a common phenotypic response of the myocardium to diverse insults rather than a single disease entity.

Classification

  • Genetic (primary): familial forms with autosomal dominant, X-linked, autosomal recessive, mitochondrial or polygenic inheritance.
  • Acquired (secondary): infectious, toxic, tachycardia-mediated, endocrine, nutritional, systemic inflammatory, neuromuscular, peripartum.
  • Modifying factors: conditions such as pregnancy can unmask a previously unnoticed DCM without being causal themselves.

Occurrence & epidemiology

The estimated lifetime prevalence is about 1 in 250. DCM can occur at any age but is most commonly diagnosed in adults younger than 50 years, and it is the most common cardiomyopathy in childhood. Men are affected more often.

Aetiopathogenesis

  • Genetics: familial disease in about 30–40 % of cases; monogenic variants are identified in 25–40 % of these. The most commonly implicated genes are TTN (titin) and LMNA (lamin A/C).
  • Infections: including coxsackievirus B, parvovirus B19, human herpesvirus 6, HIV, hepatitis B and C viruses, borreliosis, diphtheria, Chagas disease in endemic regions.
  • Toxins: alcohol, cocaine, amphetamines, cardiotoxic cytostatic agents (e.g. anthracyclines), heavy metals, carbon monoxide, radiogenic.
  • Tachycardia: persistent tachyarrhythmias, frequent ventricular ectopy or chronic right ventricular pacing can cause potentially reversible systolic dysfunction.
  • Endocrine, metabolic, nutritional: hyper- and hypothyroidism, Cushing disease, acromegaly, phaeochromocytoma; thiamine, carnitine and selenium deficiency; iron overload (hemochromatosis); electrolyte disturbances.
  • Systemic and inflammatory: rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, sarcoidosis, granulomatosis with polyangiitis, giant cell and eosinophilic myocarditis, hypereosinophilic syndrome.
  • Neuromuscular: dystrophinopathies (Duchenne, Becker), Emery-Dreifuss, limb-girdle and myotonic dystrophy, Friedreich ataxia.
  • Peripartum.

Clinical features

  • Usually insidious onset with gradually progressive symptoms; abrupt onset with acute myocarditis, takotsubo or tachycardia-mediated cardiomyopathy.
  • Left ventricular dysfunction: exertional dyspnea, orthopnea, fatigue.
  • Right ventricular involvement: peripheral edema, hepatomegaly, abdominal distension, raised jugular venous pressure.
  • Examination: third or fourth heart sound, murmur of mitral or tricuspid regurgitation, displaced apex beat, pulsus alternans in severe disease.
  • Arrhythmias: atrial and ventricular arrhythmias up to sudden cardiac death due to malignant ventricular tachyarrhythmias.

Diagnosis

  • History: detailed family history (early-onset heart disease, heart failure, sudden death), also as a basis for genetic testing.
  • Echocardiography: left ventricular dilatation with global hypokinesis and atrial enlargement; functional mitral and tricuspid regurgitation due to annular dilatation and papillary muscle displacement; sometimes regional wall motion abnormalities; contrast echo to exclude ventricular thrombus.
  • Cardiac MRI: tissue characterisation; patterns of inflammation and late gadolinium enhancement point to specific causes (e.g. myocarditis, infiltrative disease).
  • ECG and ambulatory ECG recording: normal or T-wave changes, left bundle branch block, prolonged AV conduction, atrial fibrillation; ectopy and non-sustained ventricular tachycardia are common.
  • Chest X-ray: enlarged cardiac silhouette, splaying of the carina, interstitial edema, pleural effusions.
  • Laboratory: natriuretic peptides usually raised; depending on the situation iron studies, thyroid function, viral serology and nucleic acid testing, troponin, liver and renal function.
  • Ischemia testing: exclusion of obstructive coronary artery disease.
  • Others: PET when cardiac sarcoidosis is suspected; endomyocardial biopsy in selected cases (e.g. suspected giant cell or eosinophilic myocarditis).

Treatment principles

  • Treatment follows that of heart failure with reduced ejection fraction with four pillars: ARNI or ACE inhibitor, beta blocker, mineralocorticoid receptor antagonist and SGLT2 inhibitor, supplemented by diuretics for congestion.
  • Treatable causes such as alcohol, toxins, tachycardia or myocarditis are addressed specifically, and familial forms are followed by genetic work-up.
  • If systolic function remains impaired despite optimal therapy, an ICD and cardiac resynchronisation are considered, and at end stage ventricular assist devices or transplantation.

Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.

Keep learning in the app

In the InnereFuchs app you can learn Dilated cardiomyopathy with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Dilated Cardiomyopathy
  2. StatPearls: Dilated Cardiomyopathy

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.

Related pages: Acute coronary syndrome (heart attack, STEMI/NSTEMI) · Heart failure · Atrial fibrillation

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.